|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||83.12 - 83.81|
|52 Week Range||69.35 - 89.72|
|PE Ratio (TTM)||28.86|
|Dividend & Yield||1.84 (2.21%)|
|1y Target Est||N/A|
Here's why I think Johnson & Johnson, Medtronic, and Omega Healthcare Investors will continue to deliver outsized returns for the rest of my days.
For the last several quarters, Medtronic has consistently exceeded analysts’ earnings estimates.
In fiscal 1Q18, Wall Street analysts expect Medtronic’s (MDT) revenue to be ~$7.45 billion, which represents a rise of ~4% in comparison to its fiscal 1Q17 revenue of $7.17 billion.